Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

162.70
-1.8200-1.11%
Pre-market: 162.39-0.3138-0.19%05:22 EDT
Volume:2.88M
Turnover:468.05M
Market Cap:252.35B
PE:24.36
High:163.54
Open:163.52
Low:161.18
Close:164.52
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.99
T/O Rate:0.19%
Dividend:3.23
Dividend Rate:1.99%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.02
PE(LYR):24.88

Loading ...

AstraZeneca (AZN) Gets a Sell from Deutsche Bank

TIPRANKS
·
Aug 04

AstraZeneca (AZN) Receives a Buy from UBS

TIPRANKS
·
Aug 04

More Biotech M&A is Coming, Whether an AstraZeneca-Bristol Myers Deal Happens or Not

Dow Jones
·
Aug 04

A $400 Billion Pharma Merger? RBC Says Don't Bet On It

Options & Short Sell
·
Aug 04

An AstraZeneca, Bristol Myers Squibb Merger Could Create a Cancer-Drug Giant, but Analysts Call it 'odd'

Dow Jones
·
Aug 04

TD Cowen sees no strategic logic in an AstraZeneca-Bristol Myers merger

TIPRANKS
·
Aug 04

AstraZeneca’s Elecoglipron Trial: Early Signals for a Future Oral Metabolic Franchise

TIPRANKS
·
Aug 04

AstraZeneca Slides Monday, Underperforms Market

Dow Jones
·
Aug 04

Top Midday Stories: Amazon Market Cap Hits $3 Trillion; AstraZeneca, Bristol Myers Squibb Reportedly Discuss $400 Billion Combination

MT Newswires Live
·
Aug 03

AstraZeneca PLC Stock (AZN) Moved Down by 8.54% on Aug 3: Key Drivers Unveiled

TradingKey
·
Aug 03

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 03

Bristol Myers Squibb Stock Falls on Report of $400 Billion Merger Talks with Big Rival

Dow Jones
·
Aug 03

AstraZeneca Down Nearly 8%, on Pace for Largest Percent Decrease Since April 2025

Dow Jones
·
Aug 03

Movement Alert|AstraZeneca PLC Falls 7.22% in Regular Trading, Potential $400 Billion Merger With Bristol-Myers Squibb Sparks Integration Concerns

Market Focus
·
Aug 03

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid US-Iran Truce Hopes

MT Newswires Live
·
Aug 03

Potential merger between AstraZeneca and Bristol-Myers Squibb would create a cancer drug powerhouse, but analysts call it a 'strange' deal

Deep News
·
Aug 03

Sector Update: Healthcare

MT Newswires Live
·
Aug 03

Pre-Market: Nasdaq Futures Gain 0.32% as US and Japan Jointly Intervene in Currency Markets

Deep News
·
Aug 03

U.S. Stocks on the MOVE-Atkore, Integer, Airlines

Reuters
·
Aug 03

US Stocks-Wall St Futures Gain on Mideast Deal Hopes; Healthcare in Focus

Reuters
·
Aug 03